Many physicians have become social media influencers. Their online presence has altered the patient relationship in ways we have yet ...
We're familiar with online misinformation. But we’re less familiar with how information overload affects our judgment. It’s time to study ...
We all use the internet to learn about healthcare. We think we’re gleaning information. In reality, we’re using medical content ...
A recently published study in a high-profile medical journal appeared to call into question the efficacy of colonoscopy.
Voters will decide on Proposal 3, which, if approved, would install protections for a woman’s right to have an abortion ...
About 95% of American adults are infected with the Epstein-Barr virus in their lives. And once infected, the virus stays ...
For families on low incomes, difficulty paying bills set the stage for parental mental health problems, especially for fathers.
Consumers will now be able to buy hearing aids directly off store shelves and at dramatically lower prices as federal ...
The pardoning of federal marijuana convictions may appear to be a step toward the decriminalization of drugs, but there will ...
Most providers feign confidence when they should acknowledge their uncertainty. It would improve their clinical decisions.
We unveiled the first of many surveys that capture patient perceptions. We expand on their purpose and disclose future questions.
Health officials will make public audits of Medicare Advantage health plans that reveal hundreds of millions of dollars in overcharges.
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy